Your browser doesn't support javascript.
loading
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
Black, Anna J; Zargar, Homayoun; Zargar-Shoshtari, Kamran; Fairey, Adrian S; Mertens, Laura S; Dinney, Colin P; Mir, Maria C; Krabbe, Laura-Maria; Cookson, Michael S; Jacobsen, Niels-Erik; Griffin, Joshua; Montgomery, Jeffrey S; Vasdev, Nikhil; Yu, Evan Y; Xylinas, Evanguelos; Campain, Nicholas J; Kassouf, Wassim; Dall'Era, Marc A; Seah, Jo-An; Ercole, Cesar E; Horenblas, Simon; McGrath, John S; Aning, Jonathan; Shariat, Shahrokh F; Wright, Jonathan L; Thorpe, Andrew C; Morgan, Todd M; Holzbeierlein, Jeff M; Bivalacqua, Trinity J; North, Scott; Barocas, Daniel A; Lotan, Yair; Grivas, Petros; Stephenson, Andrew J; Shah, Jay B; van Rhijn, Bas W; Spiess, Philippe E; Daneshmand, Siamak; Sridhar, Srikala S; Black, Peter C.
Afiliação
  • Black AJ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Zargar H; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Western Health, Melbourne, Australia.
  • Zargar-Shoshtari K; Department of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa FL; University of Auckland, Auckland, New Zealand.
  • Fairey AS; University of Alberta, Edmonton, AB, Canada.
  • Mertens LS; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Dinney CP; Department of Urology, MD Anderson Cancer Center, Houston, TX.
  • Mir MC; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH; Department of Urology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.
  • Krabbe LM; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Urology, University of Münster, Münster, Germany.
  • Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, OK.
  • Jacobsen NE; University of Alberta, Edmonton, AB, Canada.
  • Griffin J; Department of Urology, University of Kansas Medical Center, Kansas City, KS.
  • Montgomery JS; Department of Urology, University of Michigan Health System, Ann Arbor, MI.
  • Vasdev N; Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, Stevenage, UK; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Yu EY; Department of Medicine, Division of Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Xylinas E; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY; Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France.
  • Campain NJ; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK.
  • Kassouf W; Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada.
  • Dall'Era MA; Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, CA.
  • Seah JA; Princess Margaret Hospital, Toronto, ON, Canada.
  • Ercole CE; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Horenblas S; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • McGrath JS; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK.
  • Aning J; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK; Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
  • Shariat SF; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Wright JL; Department of Urology, University of Washington, Seattle, WA.
  • Thorpe AC; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.
  • Morgan TM; Department of Urology, University of Michigan Health System, Ann Arbor, MI.
  • Holzbeierlein JM; Department of Urology, University of Kansas Medical Center, Kansas City, KS.
  • Bivalacqua TJ; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • North S; Cross Cancer Institute, Edmonton, AB, Canada; Department of Oncology, University of Alberta, AB, Canada.
  • Barocas DA; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
  • Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Grivas P; Department of Medicine, Division of Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic.
  • Stephenson AJ; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Shah JB; Department of Urology, MD Anderson Cancer Center, Houston, TX; Department of Urology, Stanford University School of Medicine, Stanford, CA.
  • van Rhijn BW; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Spiess PE; Department of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa FL.
  • Daneshmand S; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, CA.
  • Sridhar SS; Princess Margaret Hospital, Toronto, ON, Canada.
  • Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Electronic address: peter.black@ubc.ca.
Urol Oncol ; 38(1): 3.e17-3.e27, 2020 01.
Article em En | MEDLINE | ID: mdl-31676278
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Linfócitos / Cistectomia / Terapia Neoadjuvante / Neutrófilos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Linfócitos / Cistectomia / Terapia Neoadjuvante / Neutrófilos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article